Wasatch Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-335,969
Closed -$12.4M 250
2023
Q3
$12.4M Buy
335,969
+4,610
+1% +$171K 0.08% 135
2023
Q2
$13.3M Sell
331,359
-2,814
-0.8% -$113K 0.08% 145
2023
Q1
$24.2M Sell
334,173
-1,468
-0.4% -$106K 0.15% 119
2022
Q4
$27.5M Buy
335,641
+10,186
+3% +$835K 0.19% 106
2022
Q3
$30.8M Buy
325,455
+120,386
+59% +$11.4M 0.21% 101
2022
Q2
$39.9M Buy
205,069
+52,125
+34% +$10.2M 0.25% 95
2022
Q1
$35.5M Buy
152,944
+71,923
+89% +$16.7M 0.17% 113
2021
Q4
$31.9M Sell
81,021
-35,279
-30% -$13.9M 0.13% 140
2021
Q3
$52M Buy
116,300
+20,770
+22% +$9.29M 0.21% 107
2021
Q2
$37.1M Buy
95,530
+14,252
+18% +$5.54M 0.15% 132
2021
Q1
$29.2M Buy
81,278
+2,232
+3% +$801K 0.13% 136
2020
Q4
$38.8M Sell
79,046
-30,293
-28% -$14.9M 0.19% 106
2020
Q3
$35.4M Buy
109,339
+87,087
+391% +$28.2M 0.23% 105
2020
Q2
$8.11M Buy
22,252
+16,662
+298% +$6.07M 0.06% 171
2020
Q1
$1.19M Sell
5,590
-38,454
-87% -$8.18M 0.01% 220
2019
Q4
$18.1M Buy
44,044
+16,972
+63% +$6.99M 0.15% 116
2019
Q3
$9.56M Buy
27,072
+2,854
+12% +$1.01M 0.09% 139
2019
Q2
$12.2M Buy
24,218
+7,146
+42% +$3.59M 0.12% 125
2019
Q1
$17M Buy
17,072
+3,065
+22% +$3.05M 0.18% 95
2018
Q4
$12.2M Buy
14,007
+13,436
+2,353% +$11.7M 0.16% 100
2018
Q3
$590K Sell
571
-50
-8% -$51.7K 0.01% 230
2018
Q2
$571K Buy
621
+215
+53% +$198K 0.01% 260
2018
Q1
$395K Buy
+406
New +$395K 0.01% 283